Viatris, Inc. VTRS 深沪

等待开盘 05-12 09:30:00 美东时间

16.92

-0.270

-1.57%

华盛通

立即下载

最高17.53
今开17.34
成交量 1354.86万股
最低 15.52
昨收 17.19
总市值 2050.70万
52周最高 17.53
市盈率 ^静 --
换手率 1117.87%
52周最低 8.19
委比 -45.57%
总股本 0.01亿
历史最高 18.29
量比 0.66
振幅 11.69%
历史最低 1.10
每手 1
风险率 2.26%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

FDA Takes Step Forward on Testosterone Therapy for Men

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

04-16 23:37
Earnings Scheduled For February 26, 2026

Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...

02-26 19:11
Earnings Scheduled For November 6, 2025

Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...

2025-11-06 19:12
Jefferies Maintains Buy on Viatris, Lowers Price Target to $13

Jefferies analyst Glen Santangelo maintains Viatris (NASDAQ:VTRS) with a Buy and lowers the price target from $15 to $13.

2025-03-08 01:17
应对特朗普关税冲击！具备抗压能力板块或成避风港

本周一，美国股票市场迎来了特朗普政府新关税政策生效后的首个交易日，市场一度陷入恐慌性抛售，随后跌幅有所收窄。这种市场情绪可能预示着未来的波动格局，在此背景下，投...

2025-02-04 06:00
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?

Regeneron filed an appeal after a court's decision, which was issued under seal.

2024-09-25 02:21
EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching

CC Lagator of Options AI warns traders to expect increased volatility in the week after September's 'triple witching,' with over $5 trillion in options expiring and historical evidence of market turbulence. VIX at 16 presents attractive opportunities for call option buyers.

2024-09-20 22:51
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.

2024-09-06 21:46
Viatris Launches Cash Tender Offers for Senior Notes

06:38 AM EDT, 09/04/2024 (MT Newswires) -- Viatris (VTRS) said Wednesday that the company and its units, Mylan and Utah Acquisition Sub, have launched cash tender offers to purchase all the outstanding $750 million of 1.65% senior notes due 2025 and 500 million euros ($552.7 million) of 2.125% senio...

2024-09-04 18:38
Viatris Says Late-breaking Oral Presentation Shows That Cenerimod For Systemic Lupus Erythematosus In Japanese Patients Can Be Considered Safe And Well-tolerated

The ACT-333441 study was accepted as a late-breaking abstract and was presented during an oral presentation at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress. The congress is being held August 21-25, 2024, in Suntec, Singapore.

2024-08-23 19:00

派息除权日	每股总股息	派息日期
2022-05-23	0.12	2022-06-16
2022-02-23	0.12	2022-03-16
2021-11-22	0.11	2021-12-16
2021-08-23	0.11	2021-09-16
2021-05-21	0.11	2021-06-16
2007-06-27	0.06	2007-07-16
2007-03-28	0.06	2007-04-16
2006-12-27	0.06	2007-01-16
2006-09-27	0.06	2006-10-16
2006-06-28	0.06	2006-07-14
2006-03-29	0.06	2006-04-17
2005-12-28	0.06	2006-01-13
2005-09-28	0.06	2005-10-17
2005-06-28	0.06	2005-07-15
2005-03-29	0.03	2005-04-15
2004-12-29	0.03	2005-01-14
2004-09-28	0.03	2004-10-15
2004-06-28	0.03	2004-07-15
2004-03-29	0.03	2004-04-15
2003-12-29	0.03	2004-01-15
2003-09-26	0.03	2003-10-15
2003-06-26	0.03	2003-07-15
2003-03-27	0.03	2003-04-15
2002-12-27	0.05	2003-01-15
2002-09-26	0.04	2002-10-15
2002-06-26	0.04	2002-07-15
2002-03-26	0.04	2002-04-15
2001-12-27	0.04	2002-01-15
2001-09-26	0.04	2001-10-15
2001-06-27	0.04	2001-07-16
2001-03-28	0.04	2001-04-16
2000-12-27	0.04	2001-01-15
2000-09-27	0.04	2000-10-15
2000-06-28	0.04	2000-07-15
2000-03-29	0.04	2000-04-15
1999-12-29	0.04	2000-01-14
1999-09-28	0.04	1999-10-15
1999-06-28	0.04	1999-07-15
1999-03-29	0.04	1999-04-15
1998-12-29	0.04	1999-01-15
1998-09-28	0.04	1998-10-15
1998-06-26	0.04	1998-07-15
1998-03-30	0.04	1998-04-15
1997-12-29	0.04	1998-01-15
1997-09-26	0.04	1997-10-15
1997-06-26	0.04	1997-07-15
1997-03-26	0.04	1997-04-15
1996-12-30	0.04	1997-01-15
1996-09-26	0.04	1996-10-15
1996-06-26	0.04	1996-07-15
1996-03-27	0.04	1996-04-15
1995-12-27	0.04	1996-01-15
1995-09-27	0.04	1995-10-13
1995-06-29	0.05	1995-07-14
1995-03-27	0.05	1995-04-13
1994-12-23	0.05	1995-01-13
1994-09-26	0.05	1994-10-14
1994-06-24	0.04	1994-07-15
1994-03-25	0.04	1994-04-15
1993-12-27	0.04	1994-01-14
1993-09-24	0.04	1993-10-15
1993-06-24	0.03	1993-07-15
1993-03-25	0.03	1993-04-15
1992-12-24	0.03	1993-01-15
1992-09-24	0.03	1992-10-15
1992-06-24	0.05	1992-07-15
1992-03-25	0.05	1992-04-15
1991-12-24	0.05	1992-01-15
1991-09-24	0.05	1991-10-15
1991-06-24	0.05	1991-07-15
1991-03-22	0.05	1991-04-15
1990-12-24	0.05	1991-01-15
1990-09-24	0.05	1990-10-15
1990-06-25	0.05	1990-07-16
1989-12-22	0.05	1990-01-15
1989-06-26	0.05	1989-07-17
1988-12-23	0.05	1989-01-16
1988-06-29	0.05	1988-07-15
1987-12-24	0.05	1988-01-15
1987-06-24	0.05	1987-07-15
1986-12-24	0.05	1987-01-15
1986-06-24	0.05	1986-07-15
1985-12-27	0.05	1986-01-15
1985-06-24	0.05	1985-07-19
1984-12-24	0.10	1985-01-15
1984-05-21	0.05	1984-06-13
1983-07-11	0.05	1983-08-12
1981-11-16	1.00	1981-11-13

公司名称	Viatris, Inc.
行业分类	--
业务描述	Viatris Inc.于2019年2月14日在特拉华州成立。该公司的业务在医药产品的商业化和制造方面处于全球领先地位，拥有20个全球公认的医药品牌以及一个美国的仿制药平台Greenstone。

Viatris, Inc. VTRS 深 沪

16.92

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Viatris, Inc. VTRS 深沪